Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2009 2
2010 1
2011 1
2012 5
2013 2
2014 3
2015 2
2016 1
2017 1
2019 1
2020 4
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Improving safety of gene therapy.
Räty JK, Lesch HP, Wirth T, Ylä-Herttuala S. Räty JK, et al. Among authors: lesch hp. Curr Drug Saf. 2008 Jan;3(1):46-53. doi: 10.2174/157488608783333925. Curr Drug Saf. 2008. PMID: 18690980 Review.
Avidin-biotin technology in targeted therapy.
Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S. Lesch HP, et al. Expert Opin Drug Deliv. 2010 May;7(5):551-64. doi: 10.1517/17425241003677749. Expert Opin Drug Deliv. 2010. PMID: 20233034 Review.
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy.
Eriksson RAE, Nieminen T, Galibert L, Peltola SK, Tikkanen P, Käyhty P, Lesch HP, Ylä-Herttuala S, Airenne KJ. Eriksson RAE, et al. Among authors: lesch hp. Front Med (Lausanne). 2022 Dec 13;9:1052318. doi: 10.3389/fmed.2022.1052318. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36582287 Free PMC article.
Functional roles of the membrane-associated AAV protein MAAP.
Galibert L, Hyvönen A, Eriksson RAE, Mattola S, Aho V, Salminen S, Albers JD, Peltola SK, Weman S, Nieminen T, Ylä-Herttuala S, Lesch HP, Vihinen-Ranta M, Airenne KJ. Galibert L, et al. Among authors: lesch hp. Sci Rep. 2021 Nov 4;11(1):21698. doi: 10.1038/s41598-021-01220-7. Sci Rep. 2021. PMID: 34737404 Free PMC article.
Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ, Oruetxebarria I, Lipponen EM, Leinonen HM, Käyhty P, Hynynen H, Turkki V, Malinen J, Miinalainen T, Heikura T, Parker NR, Ylä-Herttuala S, Lesch HP. Valkama AJ, et al. Among authors: lesch hp. Mol Ther Methods Clin Dev. 2020 Mar 30;17:717-730. doi: 10.1016/j.omtm.2020.03.025. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32346549 Free PMC article.
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy.
Eriksson RAE, Nieminen T, Galibert L, Peltola SK, Tikkanen P, Käyhty P, Leinonen HM, Oruetxebarria I, Lepola S, Valkama AJ, Lipponen EM, Lesch HP, Ylä-Herttuala S, Airenne KJ. Eriksson RAE, et al. Among authors: lesch hp. Front Med (Lausanne). 2023 Mar 3;10:1143748. doi: 10.3389/fmed.2023.1143748. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36936246 Free PMC article.
Biodistribution and antitumor effect of Cetuximab-targeted lentivirus.
Huhtala T, Kaikkonen MU, Lesch HP, Viitala S, Ylä-Herttuala S, Närvänen A. Huhtala T, et al. Among authors: lesch hp. Nucl Med Biol. 2014 Jan;41(1):77-83. doi: 10.1016/j.nucmedbio.2013.10.005. Epub 2013 Oct 18. Nucl Med Biol. 2014. PMID: 24267054
28 results